Paper · 42864579
The ubiquitin-proteasome system and proteostasis in the cochlea and sensorineural hearing disorders.
Zhong Y and 8 others. Mol Biomed, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The ubiquitin-proteasome system and proteostasis in the cochlea and sensorineural hearing disorders. Papers, record 42864579. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42864579
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The ubiquitin-proteasome system and proteostasis in the cochlea and sensorineural hearing disorders.
- Journal
- Mol Biomed
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-15
Source PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proteostasis | Major topic |
| Proteasome Endopeptidase Complex | Major topic |
| Ubiquitin | Major topic |
| Hearing Loss, Sensorineural | Major topic |
| Cochlea | Major topic |
| Humans | |
| Animals | |
| Proteotoxic Stress |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82301296 | National Natural Science Foundation of China | PubMed | ||
| 82471165 | National Natural Science Foundation of China | PubMed | ||
| 82301297 | National Natural Science Foundation of China | PubMed | ||
| 82501426 | National Natural Science Foundation of China | PubMed | ||
| 23ZR1440200 | Science and Technology Commission of Shanghai Municipality | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References212
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30,632,705 | TGF β-1 and WNT Signaling Pathways Collaboration Associated with Cochlear Implantation Trauma-Induced Fibrosis. | Anat Rec (Hoboken) | 2020 | https://conductscience.org/library/papers/30632705 | PubMed |
| 2 | 33,953,438 | The world report on hearing, 2021. | Bull World Health Organ | 2021 | https://conductscience.org/library/papers/33953438 | PubMed |
| 3 | 40,285,415 | VDAC1 Inhibition Protects Against Noise-Induced Hearing Loss via the PINK1/Parkin Pathway. | CNS Neurosci Ther | 2025 | https://conductscience.org/library/papers/40285415 | PubMed |
| 4 | 33,631,298 | Tauroursodeoxycholic acid attenuates cisplatin-induced ototoxicity by inhibiting the accumulation and aggregation of unfolded or misfolded proteins in the endoplasmic reticulum. | Toxicology | 2021 | https://conductscience.org/library/papers/33631298 | PubMed |
| 5 | 32,450,067 | The effect and mechanism of 19S proteasome PSMD11/Rpn6 subunit in D-Galactose induced mimetic aging models. | Exp Cell Res | 2020 | https://conductscience.org/library/papers/32450067 | PubMed |
| 6 | 30,291,149 | Age-Related Hearing Loss. | Cold Spring Harb Perspect Med | 2019 | https://conductscience.org/library/papers/30291149 | PubMed |
| 7 | 38,103,727 | RNA-seq analysis highlights DNA replication and DNA repair associated with early-onset hearing loss in the cochlea of DBA/2J mice. | Life Sci | 2024 | https://conductscience.org/library/papers/38103727 | PubMed |
| 8 | 34,095,303 | Mitophagy Impairment Aggravates Cisplatin-Induced Ototoxicity. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/34095303 | PubMed |
| 9 | 20,160,352 | Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20160352 | PubMed |
| 10 | 28,408,429 | Ubiquitin and Parkinson's disease through the looking glass of genetics. | Biochem J | 2017 | https://conductscience.org/library/papers/28408429 | PubMed |
1 to 10 of 212
See all 212 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42864579
GET https://conductscience.org/api/papers/v1/42864579/references?page=2